Dilafor
PrivateLast Round
VC Round
Apr 23, 2019
Est. Valuation
$23.01M
Company Overview
Dilafor operates in Healthcare & Life Sciences and is based in Solna. Its latest recorded funding round was a VC Round in April 2019.
Dilafor is a drug discovery company that develops pharmaceutical products aimed at minimizing the risk for maternal and fetal complications associated with labor.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dilafor Comparables
Compare Dilafor with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pfizer | 73% | |
| Gedeon Richter Plc. | 66% | |
| Bayer AG | 62% |
For institutional investors. Book with your work email.
Dilafor Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 23, 2019 | ||||
| VC Round | Sep 27, 2016 | ||||
| Corporate Funding | Oct 8, 2014 |
For institutional investors. Book with your work email.
Dilafor Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rosetta Capital | VC Round |
| The Foundation for Baltic and East European Studies | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2026
Monthly visitors increased 120% MoM.
- Jan 2, 2026
Monthly visitors increased 1169% MoM, reaching 1K.
For institutional investors. Book with your work email.
Dilafor Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Dilafor's valuation, stock price, and market status.
Is Dilafor a public or private company?
Dilafor is a private company.
What is the current stock price of Dilafor?
Dilafor is a private company, so its shares have no public market price. Caplight tracks Dilafor's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Dilafor worth (valuation)?
Dilafor's valuation is estimated at $23.0M based on funding round data.
Can I buy Dilafor stock?
Dilafor shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Dilafor's last funding round?
Dilafor's most recent funding round was VC Round on April 23, 2019.
Who are the main investors in Dilafor?
Key investors in Dilafor include Rosetta Capital.
Will Dilafor IPO soon?
No public IPO plans have been announced for Dilafor.
How can I track Dilafor secondary market activity?
Caplight tracks bids, offers, and trades in Dilafor's shares on secondary markets.